CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed
Drug / intervention
Medtronic Resting Heart Bypass Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00303641
NCT00303641Phase 1Completed
CompareCT.gov

A Prospective Randomized Study of the Safety and Effectiveness of the Medtronic Resting Heart System

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·interventional·Posted Mar 17, 2006·Updated Aug 28, 2017

In Brief

A Phase 1 clinical trial evaluating Medtronic Resting Heart Bypass System for Coronary Artery Bypass Surgery and Cardiopulmonary Bypass. Completed, across 1 site.

Detailed Summary

The purpose of this study is to determine if the Medtronic Resting Heart Bypass system is safer and results in less inflammatory reaction than traditional bypass machines used in coronary artery bypass surgery. We hypothesize that the new Medtronic Resting Heart System is safer and results in much less systemic inflammatory reaction in comparison to the standard cardiopulmonary bypass systems currently in use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Bypass Surgery, Cardiopulmonary Bypass
CountriesCanada
CollaboratorsMedtronic

Timeline

Phase 1CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 17, 2006
Enrollment StartNov 1, 2004
Primary CompletionNov 1, 2005
Study CompletionFeb 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 20.3 years ago

Interventions

Medtronic Resting Heart Bypass Systemdevice